"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 65: | Line 65: | ||
*[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | *[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | ||
*[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | *[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | ||
| + | </div> | ||
<span style="color: gold;">'''1er Constat'''</span><br> | <span style="color: gold;">'''1er Constat'''</span><br> | ||
| Line 71: | Line 72: | ||
*[[Team:SupBiotech-Paris/Concept1Fr|Concept]] | *[[Team:SupBiotech-Paris/Concept1Fr|Concept]] | ||
*[[Team:SupBiotech-Paris/Conclusion1Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion1Fr|Conclusion]] | ||
| + | </div> | ||
<span style="color: gold;">'''2nd Constat'''</span><br> | <span style="color: gold;">'''2nd Constat'''</span><br> | ||
| Line 77: | Line 79: | ||
*[[Team:SupBiotech-Paris/Concept2Fr|Concept]] | *[[Team:SupBiotech-Paris/Concept2Fr|Concept]] | ||
*[[Team:SupBiotech-Paris/Conclusion2Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion2Fr|Conclusion]] | ||
| + | </div> | ||
<span style="color: gold;">'''Mise en application'''</span><br> | <span style="color: gold;">'''Mise en application'''</span><br> | ||
Revision as of 17:12, 29 August 2009
Projet
Introduction
1er Constat
2nd Constat
Mise en application
Ressources
Ethique & sûreté
|
|
